Jan 27, 2020
Applied BioMath, LLC Announces Poster Presentation at the Tau2020 Global Conference
Oct 08, 2019
ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy
Sep 23, 2019
Michael J. Fox Foundation Announces $10-million "Ken Griffin Alpha-synuclein Imaging Competition" Spurring Development of Critical and Elusive Research Tool for Parkinson's Disease
Jun 24, 2019
Enterin's DEMET Study Enrolls First Patient With Parkinson's Disease Dementia (PDD)
Apr 11, 2019
StageBio and Tox Path Specialists Merge
Mar 19, 2019
ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson's Disease at AD/PD(TM) 2019 Conference
Mar 13, 2019
BioArctic Announces Start of Phase 1 Study of ABBV-0805 for Parkinson's Disease
Feb 22, 2019
AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies
Dec 14, 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Oct 25, 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Feb 22, 2018
Shedding a Tear May Help Diagnose Parkinson's Disease
Dec 05, 2017
ICBII Announces the Filing of Orphan Drug Designation Application for the Use of a-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy
Nov 22, 2017
Global Alpha Synuclein Market Competition by Top Manufacturers - ReportsnReports
Nov 08, 2017
Vigene Biosciences Partners with The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson's Disease Research
Jun 30, 2017
Imanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand, [18F]MK-6240
May 04, 2017
Cerveau Technologies, Inc. Signs Clinical Supply Agreement with Merck for Investigational Tau Imaging Agent